COCHW Envoy Medical, Inc. - Warrant
$0,05
Fiyat · May 19, 2026
Temel veriler itibarıyla May 11, 2026
52 Haftlık Aralık
$0–$0
30% of range
Analist Derecelendirmesi
—
Fiyat Hedefi
—
P/E (TTM)
—
ROE
—
Net Kâr Marjı
—
COCHW Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.05
Piyasa Değeri
—
P/E (TTM)
—
EPS (TTM)
$-1.23
Gelir (TTM)
$241.0K
Temettü Verimi
—
ROE
—
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$0 – $0
COCHW Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$241.0K
2022-12-31
→
2025-12-31
Hisse Başına Kâr
$-1.23
2022-12-31
→
2025-12-31
Serbest Nakit Akışı
—
2023-12-31
→
2024-12-31
Marjlar
—
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
COCHW
Akran Ortalaması
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
COCHW
Akran Ortalaması
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
COCHW
Akran Ortalaması
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
COCHW
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
7.1%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
0.56%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
COCHW
Akran Ortalaması
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 15
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $241.0K | $225.0K | $316.0K | $237.0K | |
| Cost of Revenue | $874.0K | $742.0K | $789.0K | $498.0K | |
| R&D Expense | $12M | $10M | $9M | $5M | |
| SG&A Expense | $8M | $7M | $7M | $3M | |
| Operating Expenses | $23M | $19M | $19M | $9M | |
| Operating Income | $-22M | $-19M | $-18M | $-9M | |
| Interest Income | · | · | · | $6M | |
| Other Non-op | $-23.0K | $-26.0K | $54.0K | $-127.0K | |
| Pretax Income | $-24M | $-21M | · | $21M | |
| Net Income | $-24M | $-21M | $-30M | $-16M | |
| EPS (Basic) | $-1.23 | $-1.49 | $-2.54 | $-1.57 | |
| EPS (Diluted) | $-1.23 | $-1.49 | $-2.54 | $-1.57 | |
| Shares (Basic) | 23,259,598 | 18,790,448 | 12,295,391 | 10,123,169 | |
| Shares (Diluted) | 23,259,598 | 18,790,448 | 12,295,391 | 10,123,169 | |
| EBITDA | · | $-19M | $-18M | $-5M |
Bilanço 21
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $5M | $4M | $183.0K | |
| Receivables | $34.0K | $38.0K | $70.0K | $41.0K | |
| Inventory | $2M | $2M | $1M | $1M | |
| Prepaid Expense | $941.0K | $887.0K | $2M | $129.0K | |
| Current Assets | $6M | $9M | $7M | $2M | |
| PP&E (Net) | $1M | $1M | $351.0K | $331.0K | |
| PP&E (Gross) | $6M | $6M | $5M | · | |
| Accum. Depreciation | $5M | $5M | $5M | · | |
| Total Assets | $9M | $12M | $8M | $3M | |
| Accounts Payable | $3M | $2M | $2M | $1M | |
| Accrued Liabilities | $8M | $4M | $5M | $608.0K | |
| Current Liabilities | $12M | $8M | $7M | $3M | |
| Other Non-current Liabilities | $27.0K | $891.0K | · | $127.0K | |
| Total Liabilities | $20M | $30M | $10M | $39M | |
| Common Stock | $3.0K | $2.0K | · | · | |
| Paid-in Capital | $301M | $266M | $256M | $190M | |
| Retained Earnings | $-313M | $-285M | $-257M | $-226M | |
| AOCI | $-120.0K | $-123.0K | $-118.0K | $-115.0K | |
| Stockholders' Equity | $-12M | $-19M | $-2M | $-36M | |
| Liabilities + Equity | $9M | $12M | $8M | $3M | |
| Shares Outstanding | · | 21,326,609 | 18,599,982 | · |
Nakit Akışı 10
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $657.0K | $562.0K | $2M | · | |
| Deferred Tax | · | $3M | $6M | $645.0K | |
| Operating Cash Flow | $-18M | $-18M | $-17M | $-9M | |
| CapEx | $179.0K | $980.0K | $153.0K | $218.0K | |
| Investing Cash Flow | $-179.0K | $-980.0K | $-153.0K | $-218.0K | |
| Stock Issued | $414.0K | · | $109.0K | · | |
| Dividends Paid | $2M | $2M | · | · | |
| Financing Cash Flow | $17M | $20M | $21M | $8M | |
| Net Change in Cash | $-2M | $1M | $4M | $-938.0K | |
| Free Cash Flow | · | $-19M | $-18M | · |
Kârlılık 6
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | · | -8558.2% | -5813.6% | · | |
| Net Margin | · | -9242.2% | -9464.6% | · | |
| EBITDA Margin | · | -8558.2% | -5813.6% | · | |
| ROA | · | -210.0% | -586.7% | 4.5% | |
| ROE | · | 111.2% | -1978.0% | -88.5% | |
| ROIC | · | · | · | 25.3% |
Likidite ve Solventlik 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | · | 1.2 | 1.0 | 0.0 | |
| Quick Ratio | · | 0.7 | 0.6 | 0.0 |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | 0.1 | · | |
| Inventory Turnover | · | 0.5 | 0.6 | · | |
| Receivables Turnover | · | 4.2 | 5.7 | · |
Büyüme Oranları 2
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 7.1% | -28.8% | 33.3% | · | |
| Revenue CAGR 3Y | 0.56% | · | · | · |
Değerleme (TTM) 4
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $241.0K | $225.0K | $316.0K | $237.0K | |
| Net Income TTM | $-24M | $-21M | $-30M | $-16M | |
| Payout Ratio | · | -11.8% | · | · | |
| Annual Payout | $2M | $2M | · | · |
Gelir Tablosu 16
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $39.0K | $75.0K | $42.0K | $78.0K | $46.0K | $42.0K | $56.0K | $68.0K | $59.0K | $95.0K | $80.0K | $63.0K | $78.0K | $20.0K | $57.0K | |
| Cost of Revenue | $313.0K | $211.0K | $203.0K | $234.0K | $226.0K | $157.0K | $187.0K | $245.0K | $153.0K | $263.0K | $189.0K | $162.0K | $175.0K | $151.0K | $106.0K | |
| R&D Expense | $4M | $5M | $3M | $2M | $3M | $2M | $3M | $3M | $2M | $3M | $2M | $2M | $2M | $1M | $935.0K | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $3M | $1M | $2M | $1M | $447.0K | $812.0K | |
| Operating Expenses | $6M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $7M | $3M | $5M | $4M | $3M | $2M | |
| Operating Income | $-6M | $-6M | $-6M | $-5M | $-5M | $-5M | $-5M | $-5M | $-5M | $-7M | $-3M | $-4M | $-4M | $-5M | $-2M | |
| Interest Income | · | · | · | · | · | · | · | · | · | · | · | $528.3K | $3M | · | $2M | |
| Other Non-op | $6.0K | $-16.0K | $5.0K | $-1.0K | $-11.0K | $-17.0K | $13.0K | $-8.0K | $-14.0K | $113.0K | $46.0K | · | $-9M | $-8.0K | $-117.0K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | · | $-1M | $2M | · | $6M | |
| Income Tax | · | · | · | · | · | · | · | · | · | · | · | $121.2K | $841.5K | · | $534.0K | |
| Net Income | $-4M | $-7M | $-6M | $-6M | $-5M | $-5M | $-6M | $-4M | $-6M | $-5M | $2M | $-13M | $-13M | $-11M | $-1M | |
| EPS (Basic) | $-0.08 | $-0.27 | $-0.35 | $-0.32 | $-0.29 | $-0.40 | $-0.39 | $-0.29 | $-0.41 | $-0.05 | $0.13 | $-1.31 | $-1.31 | $-1.13 | $-0.13 | |
| EPS (Diluted) | $-0.08 | $-0.27 | $-0.35 | $-0.32 | $-0.29 | $-0.40 | $-0.39 | $-0.29 | $-0.41 | $-0.05 | $0.13 | $-1.31 | $-1.31 | $-1.13 | $-0.13 | |
| Shares (Basic) | 68,934,960 | -41,302,469 | 21,851,606 | 21,383,852 | 21,326,609 | -37,025,878 | 18,616,362 | 18,599,982 | 18,599,982 | -18,163,954 | 10,214,183 | 10,122,581 | 10,122,581 | -18 | 10,123,187 | |
| Shares (Diluted) | 68,934,960 | -41,302,469 | 21,851,606 | 21,383,852 | 21,326,609 | -37,025,878 | 18,616,362 | 18,599,982 | 18,599,982 | -19,164,839 | 11,215,068 | 10,122,581 | 10,122,581 | -18 | 10,123,187 | |
| EBITDA | $-6M | · | $-6M | $-5M | $-5M | · | $-5M | $-5M | $-5M | · | $-3M | $-98.6K | $-2M | · | $-1M |
Bilanço 22
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $25M | $4M | $4M | $5M | $5M | · | $4M | $2M | $5M | $4M | $7M | $132.8K | $104.0K | $183.0K | $302.0K | |
| Receivables | $31.0K | $34.0K | $35.0K | $43.0K | $42.0K | $38.0K | $197.0K | $174.0K | $189.0K | $70.0K | $109.0K | · | · | $41.0K | · | |
| Inventory | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | · | · | $1M | · | |
| Prepaid Expense | $893.0K | $941.0K | $508.0K | $576.0K | $1M | $887.0K | $842.0K | $1M | $1M | $2M | $997.0K | $264.9K | $412.9K | $129.0K | $288.2K | |
| Current Assets | $28M | $6M | $6M | $8M | $8M | $9M | $7M | $5M | $8M | $7M | $20M | $397.7K | $516.9K | $2M | $590.2K | |
| PP&E (Net) | $962.0K | $1M | $1M | $1M | $1M | $1M | $1M | $632.0K | $317.0K | $351.0K | $378.0K | · | · | $331.0K | · | |
| PP&E (Gross) | $6M | $6M | $6M | $6M | $6M | $6M | · | · | · | $5M | · | · | · | · | · | |
| Accum. Depreciation | $5M | $5M | $5M | $5M | $5M | $5M | · | · | · | $5M | · | · | · | · | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | $10M | · | · | · | · | |
| Total Assets | $30M | $9M | $8M | $10M | $10M | $12M | $9M | $7M | $8M | $8M | $21M | $45M | $46M | $3M | $428M | |
| Accounts Payable | $2M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $913.0K | $2M | $3M | $1M | $2M | $1M | $1M | |
| Accrued Liabilities | $10M | $8M | $6M | $5M | $5M | $4M | $7M | $6M | $6M | $5M | $4M | $5M | $6M | $608.0K | $3M | |
| Current Liabilities | $12M | $12M | $9M | $8M | $8M | $8M | $9M | $8M | $7M | $7M | $13M | $9M | $9M | $3M | $6M | |
| Other Non-current Liabilities | $27.0K | $27.0K | $891.0K | $891.0K | $891.0K | $891.0K | · | · | · | · | · | · | · | · | · | |
| Total Liabilities | $19M | $20M | $16M | $40M | $35M | $30M | $28M | $19M | $16M | $10M | $16M | $21M | $21M | $39M | $18M | |
| Common Stock | $8.0K | $3.0K | $2.0K | $2.0K | $2.0K | $2.0K | · | · | · | · | · | · | · | · | · | |
| Paid-in Capital | $329M | $301M | $298M | $268M | $267M | $266M | $259M | $258M | $258M | $256M | $256M | · | · | $190M | · | |
| Retained Earnings | $-319M | $-313M | $-306M | $-298M | $-291M | $-285M | $-278M | $-270M | $-265M | $-257M | $-251M | $-21M | $-19M | $-226M | $-17M | |
| AOCI | $-121.0K | $-120.0K | $-120.0K | $-119.0K | $-117.0K | $-123.0K | $-121.0K | $-120.0K | $-119.0K | $-118.0K | $-116.0K | · | · | $-115.0K | · | |
| Stockholders' Equity | $10M | $-12M | $-8M | $-30M | $-24M | $-19M | $-19M | $-12M | $-7M | $-2M | $5M | $-21M | $-19M | $-36M | $-17M | |
| Liabilities + Equity | $30M | $9M | $8M | $10M | $10M | $12M | $9M | $7M | $8M | $8M | $21M | $45M | $46M | $3M | $428M | |
| Shares Outstanding | · | · | · | 21,520,932 | 21,326,609 | · | · | · | · | · | 19,549,982 | · | · | · | · |
Nakit Akışı 11
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $239.0K | $179.0K | $172.0K | $146.0K | $160.0K | $153.0K | $144.0K | $142.0K | $123.0K | · | · | · | · | · | · | |
| Operating Cash Flow | $-6M | $-6M | $-4M | $-4M | $-4M | $-5M | $-2M | $-4M | $-6M | $-11M | $-3M | $-5M | $-3M | $-2M | $-5M | |
| CapEx | · | $172.0K | $0 | $1.0K | $6.0K | $-534.0K | $1M | · | · | $21.0K | $62.0K | $11.0K | $59.0K | $41.0K | · | |
| Investing Cash Flow | · | $-172.0K | $0 | $-1.0K | $-6.0K | $534.0K | $-615.0K | $-790.0K | $-109.0K | $-21.0K | $-389M | $-389M | $-59.0K | $-41.0K | · | |
| Stock Issued | $30M | $0 | $210.0K | · | · | · | $0 | $0 | $2M | · | · | · | · | · | · | |
| Net Stock Activity | $30M | · | · | · | · | · | · | · | $2M | · | · | · | · | · | · | |
| Dividends Paid | · | $-1.0K | $0 | $607.0K | $1M | $614.0K | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $28M | $6M | $3M | $4M | $4M | $6M | $5M | $2M | $6M | $-1M | $409M | $394M | $4M | $2M | $5M | |
| Net Change in Cash | $22M | $183.0K | $-2M | $-25.0K | $-171.0K | $1M | $3M | $-3M | $727.0K | $-13M | $17M | $-111.2K | $931.0K | $-426.0K | $-839.1K | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | $318.5K | · | · | · | |
| Free Cash Flow | · | · | · | · | $-4M | · | · | · | · | · | · | · | · | · | · |
Kârlılık 6
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -15279.5% | · | -13590.5% | -6500.0% | -11102.2% | · | -8882.1% | -7147.1% | -8301.7% | · | -4231.2% | · | · | · | · | |
| Net Margin | -11156.4% | · | -15433.3% | -7294.9% | -10865.2% | · | -10642.9% | -5804.4% | -10627.1% | · | 1953.8% | · | · | · | · | |
| EBITDA Margin | -15279.5% | · | -13590.5% | -6500.0% | -11102.2% | · | -8882.1% | -7147.1% | -8301.7% | · | -4231.2% | · | · | · | · | |
| ROA | -21.6% | · | -73.8% | -68.4% | -53.0% | · | -38.9% | -15.2% | -23.1% | · | 0.70% | -0.48% | 0.30% | · | 1.3% | |
| ROE | 61.9% | · | 49.5% | 26.9% | 31.6% | · | 86.7% | 23.8% | 47.1% | · | -24.9% | 5.4% | -3.3% | · | -22.7% | |
| ROIC | · | · | · | · | · | · | · | · | · | · | · | 0.53% | 6.0% | · | 5.4% |
Likidite ve Solventlik 2
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.3 | · | 0.6 | 0.9 | 1.1 | · | 0.8 | 0.6 | 1.1 | · | 1.6 | 0.0 | 0.1 | · | 0.1 | |
| Quick Ratio | 2.1 | · | 0.4 | 0.7 | 0.7 | · | 0.5 | 0.2 | 0.7 | · | 0.6 | 0.0 | 0.0 | · | 0.1 |
Verimlilik 3
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · | · | · | |
| Inventory Turnover | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.3 | 0.2 | · | 0.3 | · | · | · | · | |
| Receivables Turnover | 1.1 | · | 0.4 | 0.7 | 0.4 | · | 0.4 | 0.8 | 0.6 | · | 1.5 | · | · | · | · |
Değerleme (TTM) 5
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $205.0K | · | $222.0K | $248.0K | $229.0K | · | $263.0K | $270.0K | $280.0K | · | $278.0K | · | · | · | · | |
| Net Income TTM | $-22M | · | $-23M | $-21M | $-21M | · | $-15M | $-22M | $-31M | · | $-26M | $-29M | $-18M | · | $1M | |
| P/E | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -2189.5% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Payout Ratio | · | · | · | · | -24.3% | · | · | · | · | · | · | · | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $241.0K | $225.0K | $316.0K | $237.0K | — |
| Faaliyet Kâr Marjı % | — | -8558.2% | -5813.6% | — | — |
| Net Gelir | $-24M | $-21M | $-30M | $-16M | $-251.6K |
| Seyreltilmiş Hisse Başı Kâr | $-1.23 | $-1.49 | $-2.54 | $-1.57 | — |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | — | 1.2 | 1.0 | 0.0 | 0.3 |
| Cari Oran | — | 0.7 | 0.6 | 0.0 | 0.1 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | — | $-19M | $-18M | — | — |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.